Obalon Therapeutics (OBLN) Announces Further Impacts Related To Covid-19 Crisis and Current Business Environment May 11, 2020 08:31AM
Obalon Announces Further Impacts Related To Covid-19 Crisis and Current Business Environment May 11, 2020 08:30AM
Obalon Announces Further Impacts Related To Covid-19 Crisis and Current Business Environment May 11, 2020 08:30AM
Obalon Therapeutics (OBLN) Engages Canaccord Genuity to Explore Financial and Strategic Alternatives Mar 25, 2020 08:35AM
Obalon Engages Canaccord Genuity to Explore Financial and Strategic Alternatives Mar 25, 2020 08:30AM


Mar 25, 2020 08:30AM Obalon Engages Canaccord Genuity to Explore Financial and Strategic Alternatives
Nov 14, 2019 09:00AM Obalon To Present at Two Upcoming Institutional Investor Conferences
Aug 5, 2019 09:00AM Obalon Therapeutics to Present at the Canaccord Genuity 39th Annual Growth Conference
Jul 10, 2019 08:30AM Obalon Strengthens Balance Sheet By Raising Additional Capital And Reducing Debt
May 22, 2019 07:11AM Obalon Therapeutics (OBLN) PT Lowered to $1 at Canaccord Genuity
Apr 8, 2019 07:07AM Canaccord Genuity Downgrades Obalon Therapeutics (OBLN) to Hold
Dec 27, 2018 05:53PM Obalon Therapeutics, Inc. Announces Two Agreements To Provide Up To $30 Million of Capital
Dec 27, 2018 05:53PM Obalon Therapeutics, Inc. Announces Two Agreements To Provide Up To $30 Million of Capital
Nov 6, 2018 09:15AM Obalon Announces Upcoming Conference Presentations
Aug 7, 2018 09:02AM Obalon Announces Upcoming Conference Presentation
Aug 7, 2018 09:02AM Obalon Announces Upcoming Conference Presentation
Aug 2, 2018 01:23PM Obalon Therapeutics (OBLN) PT Lowered to $2.50 at Canaccord Genuity; Keeps 'Buy'
May 11, 2018 01:04AM Obalon Therapeutics (OBLN) PT Lowered to $6 at Canaccord Genuity
Mar 6, 2018 05:59AM Obalon Therapeutics (OBLN) PT Lowered to $10 at Canaccord Genuity
Jan 23, 2018 09:15AM Obalon Therapeutics (OBLN) Terminates Offering of Common Stock After Whistleblower Contacts Auditor KPMG
Jan 23, 2018 09:13AM Obalon Announces Termination of Public Offering of Common Stock
Jan 23, 2018 09:13AM Obalon Announces Termination of Public Offering of Common Stock
Jan 19, 2018 05:45AM Obalon Therapeutics (OBLN) Prices 5.45m Share Common Offering at $5.50/Sh
Jan 18, 2018 10:00PM Obalon Therapeutics Prices Public Offering of Common Stock
Jan 18, 2018 10:00PM Obalon Therapeutics Prices Public Offering of Common Stock
Jan 16, 2018 04:01PM Obalon Therapeutics (OBLN) Commences $35M Offering of Common Stock
Jan 16, 2018 04:01PM Obalon Therapeutics Announces Proposed Public Offering of Common Stock
Jan 16, 2018 04:01PM Obalon Therapeutics Announces Proposed Public Offering of Common Stock
Nov 6, 2017 08:46AM Obalon Announces Upcoming Conference Presentations
Jul 31, 2017 08:45AM Obalon Announces Upcoming Conference Presentation
Oct 31, 2016 07:54AM Canaccord Genuity Starts Obalon Therapeutics (OBLN) at Buy
Oct 6, 2016 11:00AM Obalon Therapeutics (OBLN) IPO Opens Modestly Higher
Oct 6, 2016 05:53AM Obalon Therapeutics (OBLN) 5M Share Common Stock IPO at Midpoint of Expected Range
Oct 5, 2016 07:46PM Obalon Therapeutics Announces Pricing of Initial Public Offering